Laboratory research studies validate a revolutionary treatment for joint inflammation research on Sasha's Equine, and the components of Sasha's Blend/JointXL.

The studies are creating a buzz in the scientific community, and could point to a “ holy grail” for joint inflammation sufferers.

For immediate release - November 30, 2006

Interpath Pty Ltd., is pleased to announce the release of breakthrough research findings from a three-year study of “the efficacy and safety of the constituents (abalone, shark cartilage, perna mussel)” contained in the products Sasha's Blend ™ (for pets) Sasha's Equine ™ (for horses) and the human formulation Joint XL™.

The research was carried out by Ph.D. researcher Wendy Pearson, under the supervision of Dr. Michael Lindinger, Associate Professor for the Department of Human Health and Nutritional Sciences at the University of Guelph.

  • In a Laboratory model reproducing digestive and absorption processes, it was found that cartilage treated with Sasha's EQ™/Sasha's Blend™ / JointXL™:
  • Produced less of the pain-transmitters nitric oxide and prostaglandin E2 than controls, strongly suggesting a vehicle for pain reduction.
  • Reduced the incidence of glycosaminoglycan (GAG) release in joints, a process which can demonstrably weaken cartilage integrity.
    Increased the production of chondrocytes, the cells that regenerate healthy cartilage.

What the research means to people/animals with arthritis:

  • Less pain associated with joint movement
  • Less destruction of cartilage due to free radials
  • Less destruction due to degradation of proteoglycan (building blocks of cartilage)

Ph.D. researcher/scientist Wendy Pearson is available for interviews.

 

About Sasha's Blend™

Sasha's Blend™ is a carefully-developed all-natural whole food additive harvested from the sea. It is a concentrated powdered mix of abalone, shark cartilage, New Zealand Green Lipped Mussel and other natural ingredients (no fillers). It has been manufactured in a way to maintain maximum integrity of the actives, and naturally provide as many of the nutrients required to help keep joints healthy. These ingredients have been carefully blended to produce a high-quality, highly effective anti-inflammatory, which is designed not only to reduce pain and inflammation, but also to protect cartilage from breakdown associated with arthritis and other inflammatory cartilage conditions. It is safe to take as an adjunct to other treatments and some components have been found to be gastro-protective when taken with other anti-inflammatory treatments. In a clinical study performed in Australia on dogs with joint issues, over 90% of dogs taking Sasha's Blend™ showed significant improvement.

About Interpath Pty Ltd.

Interpath Pty Ltd. is an industry leader specializing in the scientific research and development for the treatment of tissue and cellular inflammation. The company is globally positioned as the forerunner in the revolution of non-pharmaceutical treatment of arthritis and prevention of joint disease in humans and animals. Interpath Pty Ltd. was established with a view to developing global markets for health-based products. For product information visit www.sashasblend.com - www.jointxl.com

Interpath Pty Ltd. is a privately-held multi-national company headquartered in Ballarat Australia, with offices in the U.S., Canada, The Netherlands, and South Africa, and distributors in Ireland, New Zealand, China, Singapore, Japan, Hong Kong and Portugal. It also has contracted research facilities in Australia, Canada and New Zealand. For more information visit Interpath's website at www.interpath.net.au.

Download PDF with more information




close this window